We are trailblazers in the development of engineered bacteriophage products. Applying modern
technologies, we are revolutionizing the treatment of bacterial infections and addressing unmet
medical needs across immunology, oncology, and CNS disorders.
From state-of-the-art robotics and automated biobanking to Al-driven cocktail prediction tools and
cutting-edge synthetic biology techniques, we’re engineering phage cocktails with payloads that
make them far more effective than their natural phage counterparts.
Learn more about how our clinical success sets us apart and how our world-class viral vector
manufacturing facility produces cGMP clinical trial material at unprecedented potency and purity.
Our teams bring strong scientific foundations across biology, chemistry, engineering, and data science, allowing us to address complex challenges with accuracy, consistency, and a deep understanding of modern life sciences.
We support the full product lifecycle, from early discovery and development to clinical research and commercial manufacturing, reducing fragmentation and ensuring seamless project execution.
Our workflows are built to meet international regulatory and quality standards, ensuring full compliance with global authorities such as FDA and EMA across all stages.
By applying cutting-edge biotechnologies, digital platforms, and data-driven tools, we enhance efficiency, improve accuracy, and accelerate informed decision-making.
Transforming research into real-world solutions by developing engineered bacteriophage products, precision medicines, and advanced therapies.
With robust quality systems, proven processes, and consistent delivery, we build long-term relationships based on trust, performance, and measurable results.
To accelerate scientific innovation and deliver biotechnological solutions that improve human health, extend life expectancy, and address global medical and environmental challenges.
We provide advanced discovery platforms that support target identification, biomarker discovery, and molecular characterization.
Our integrated preclinical solutions help de-risk drug candidates and accelerate development timelines.
We support clinical programs from Phase I through Phase IV with a focus on data integrity, patient safety, and regulatory compliance.
What you will get in this plan
$129.99/yearly
What you will get in this plan
$159.99/yearly
What you will get in this plan
$229.99/yearly
We enable the development of advanced therapies through specialized platforms for cellular and genetic engineering.
Viral & non-viral vector development
We integrate advanced data science with biological research to unlock deeper insights, accelerate development, and improve decision-making across the life sciences value chain. By transforming complex biological data into actionable intelligence, we enable smarter, faster, and more predictive science.
Our digital biotechnology capabilities bridge experimental research and computational analysis, allowing organizations to move beyond traditional trial-and-error approaches toward data-driven innovation.
We apply sophisticated bioinformatics pipelines and statistical models to analyze large-scale biological datasets, including genomics, transcriptomics, proteomics, and metabolomics. This enables precise interpretation of biological mechanisms, disease pathways, and therapeutic targets.
